The Department of Justice (DOJ) has filed a nationwide lawsuit against Walmart Inc. According to a civil complaint the DOJ filed, Walmart pharmacies across the country unlawfully dispensed controlled substances. At the height of the country’s prescription opioid crisis, Walmart unlawfully distributed such drug to their pharmacies, according to the complaint.
For years, media outlets, medical practitioners, and legal professionals have publicized, studied, treated, and represented women who endured health issues after receiving pelvic/transvaginal mesh implants.
Johnson & Johnson is the defendant in more than 20,000 lawsuits that allege the company’s talcum-based Johnson’s Baby Powder and Shower-to-Shower caused plaintiffs to develop mesothelioma and ovarian cancer. In one such case, Olson v. Brenntag N. Am., Inc., plaintiffs Donna Olson and Robert Olson thought they had won big in their suit.
Three types of highly textured implants can no longer be supplied or imported to, or exported from, Australia. On October 29, the Therapeutic Goods Administration (TGA) had dropped the following three breast implant entries from the Australian Register of Therapeutic Goods (ARTG), effective October 27, 2020:
On February 23, 2020, the American Society of Retina Specialists (ASRS) warned members about the side effects of Beovu, an injectable drug used to treat wet age-related macular degeneration. The organization reported results from a study revealing side effects of retinal vasculitis and the more serious retinal artery occlusion.
An explosion of recent studies from multiple university medical centers recently exposed that the use of the prescription drug Elmiron® can result in patients’ vision failure, up to and including legal blindness. Elmiron® is the brand name for pentosane polysulfate sodium (“PPS”), a drug manufactured and distributed by Janssen Pharmaceuticals. It has been marketed for nearly twenty-five years and resulted in billions of dollars of sales for Janssen. The earliest clinical trials for Elmiron® from the 1990s revealed not only dubious efficacy, but also a hos
With 80 product liability lawsuits already filed and hundreds more likely to follow, lawyers are discussing the coordination of multi-district litigation (MDL). To date, legal action has been taken against Johnson & Johnson’s Janssen Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., and other pharma companies.
Plaintiffs allege that these companies knowingly withheld risks connected with long-term use of the drug. Complaints list such outcomes as retinal damage and blurred and distorted vision.
After four years of litigation between plaintiffs and Johnson & Johnson, the multinational corporation agreed to the first set of major settlements. The agreement to pay $100 million will resolve more than 1,000 lawsuits in which plaintiffs allege that the talc in Johnson & Johnson’s signature baby powder causes cancer, according to a Bloomberg report. This settlement marks the first to come from almost 20,000 lawsuits.
In 2016, residents in Hoosick Falls, New York, learned that for years they had been drinking water contaminated with perfluorooctanoic acid (PFOA). One resident, Nikki Aldrich, carried her two children during this period of contamination.
Aearo Technologies’ Combat Arms earplugs were standard issue for U.S. soldiers fighting in Iraq and Afghanistan. The devices were hailed as groundbreaking technology that enabled soldiers to protect their hearing while still being able to hear commands amidst war zones.
On September 1, 2020, District Judge Edmund A. Sargus, the presiding judge for In re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Prods. Liab. Litig., MDL No. 2846, issued the summary judgment ruling in the first bellwether trial. Johns v. C.R. Bard, Inc., is a Ventralight™ ST case which is a defense pick and which is set for trial on January 11, 2021. The ruling leaves intact nearly all of the plaintiff’s legal theories of relief but trimmed the scope of compensatory damages available to the plaintiff.
When drinking water supplies around Fayetteville, North Carolina proved to be contaminated, all fingers pointed to per- and polyfluoroalkyl substances (PFAS) manufactured at Chemours’ Fayetteville Works plant. U.S. Rep. Richard Hudson, R-N.C. called a roundtable meeting to discuss the pollution. The meeting included various local officials, but the A-list attendee had to have been federal Environmental Protection Agency (EPA) Administrator Andrew Wheeler.
U.S. Court of Appeals for the Ninth Circuit upheld damages awarded to a patient who suffered heart damage from C.R. Bard’s clot-stopping vein filter. The court ruled that the U.S. Food and Drug Administration’s edicts did not pre-empt Georgia’s state law underscoring a duty to warn.
In 2007, patient Sherr-Una Booker underwent a surgical procedure to place a Bard’s G2 model inferior vena cava (IVC) filter near her heart. When fragments of the filter became detached, Booker was forced to under heart revision surgery.
A class-action lawsuit might be taking shape against Geico auto insurance company. When the insurer announced its 15% “Geico Giveback” premium discount program in April, consumers understood it would reflect the dramatic reduction in driving during the COVID-19 crisis. Consumers, however, think the country’s second largest auto insurer undelivered on its promise, and they have taken legal action.
In September 2019, the U.S. Food & Drug Administration reported that at least 12 women had died from breast implant associated anaplastic large cell lymphoma (BIA-ALCL)—a rare cancer of the immune system—caused by textured breast implants and tissue expanders made by Allergan.
In a press release announcing second-quarter earnings, Bayer AG reported that it has reserved $1.47 billion (1.25 billion euros) for the potential settlement of Essure contraceptive device lawsuits filed against the company. Some of the funds set aside will be used in settlement for other lawsuits the company faces.